Tools for Practice Outils pour la pratique


#301 Under Pressure: Compression stockings for recurrent cellulitis?


CLINICAL QUESTION
QUESTION CLINIQUE
Does the use of compression stockings in patients with chronic lower limb edema decrease cellulitis recurrence?


BOTTOM LINE
RÉSULTAT FINAL
In patients with chronic leg edema and recurrent cellulitis, compression therapy reduced recurrence to 15% compared to 40% with education alone at 6 months. Compression stockings are a good treatment option for patients without contraindications, although real-world patient uptake may be limited.



CFPCLearn Logo

Reading Tools for Practice Article can earn you MainPro+ Credits

La lecture d'articles d'outils de pratique peut vous permettre de gagner des crédits MainPro+

Join Now S’inscrire maintenant

Already a CFPCLearn Member? Log in

Déjà abonné à CMFCApprendre? Ouvrir une session



EVIDENCE
DONNÉES PROBANTES
  • Randomized control trial of 84 patients with edema for ≥3 months and history of cellulitis (≥2 episodes in the same leg in past two years).1 Compression individualized (primarily knee-high, 23-32 mmHg).2 Results statistically significant unless noted.
    • Compression plus education compared to education alone. At 6 months:
      • Recurrence of cellulitis: 15% compression versus 40% education, number needed to treat=4.
      • Quality of life: Improved 8 points (scale 0-100, higher better), study underpowered for this outcome and did not reach statistical significance.
      • Adherence: 88% of compression group reported wearing garments ≥4 days/week.
      • No adverse events reported.
    • Limitations: Non-blinded; support provided by lymphedema physiotherapists which may limit general applicability; trial stopped early for benefit.
  • Prospective cohort study of 107 patients with chronic edema: Edema care (including daily compression, exercise, and skin care) administered via community services model reduced the incidence of cellulitis from 41.5/100 patient-years at baseline to zero at 6–12 months.3
Context
  • While higher levels of compression(20-60mmHg) may be better for reducing edema, lower levels (10-20mmHg) also reduce edema and may result in better compliance.4,5 
    • Only a third of patients with a history of cellulitis reported willingness to wear compression stockings for future prevention.6
  • Factors that increase the risk of cellulitis in chronic edema include wounds, male sex, diabetes, and obesity.7
  • Compression stockings have been demonstrated to increase complete healing of venous ulcers compared to no compression within 12 months (70% stockings versus 40%).8
  • Price and coverage vary significantly. Price increases with strength (example: below-knee 15-20mmHg ~$30, 20-30mmHg ~$85).
  • Contraindications to compression stockings include severe heart failure (risk of fluid overload) and critical limb ischemia.4


Alison Trant November 5, 2021

Useful
Sometimes my patients are reluctant because compression socks are hard to put on. I will consider trying lower pressure stockings for these patents


Latest Tools for Practice
Derniers outils pour la pratique

#379 Bumpin’ Up the Protection? RSV Vaccine in Pregnancy

How effective and safe is the respiratory syncytial virus (RSV) vaccine (AbrysvoTM) when given during pregnancy?
Read Lire 0.25 credits available Crédits disponibles

#378 Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?

What is the efficacy and safety of romosozumab in postmenopausal women with osteoporosis?
Read Lire 0.25 credits available Crédits disponibles

#377 How to slow the flow IV: Combined oral contraceptives

In premenopausal heavy menstrual bleeding due to benign etiology, do combined oral contraceptives (COC) improve patient outcomes?
Read Lire 0.25 credits available Crédits disponibles

This content is certified for MainPro+ Credits, log in to access

Ce contenu est certifié pour les crédits MainPro+, Ouvrir une session


Author(s)
Auteur(s)
  • Jamie Grunwald
  • Christina Korownyk MD CCFP
  • Betsy Thomas BSc. Pharm

1. Webb E, Neeman T, Bowden FJ, et al. N Engl J Med. 2020; 383(7):630-639.

2. Personal communication Dr. Elizabeth Webb, July 21, 2021.

3. Moffatt CJ, Doherty DC, Franks PJ, et al. Lymphat Res Biol. 2018; 16(1):92-99.

4. Rabe E, Partsch H, Hafner J, et al. Phlebology. 2018; 33(3):163-184.

5. Kapp S, Miller C, Donohue L. Int J Low Extrem Wounds. 2013 Sep; 12(3):189-98.

6. Teasdale EJ, Lalonde A, Muller I, et al. Br J Dermatol. 2019; 180(4):810-820.

7. Burian EA, Karlsmark T, Franks PJ, et al. Br J Dermatol. 2021; 185(1):110-118.

8. Shi C, Dumville JC, Cullum N, et al. Cochrane Database Syst Rev. 2021 Jul 26; 7:CD013397.

Authors do not have any conflicts of interest to declare.

Les auteurs n’ont aucun conflit d’intérêts à déclarer.